12-57570045-G-C
Variant summary
Our verdict is Benign. The variant received -7 ACMG points: 0P and 7B. BP4_ModerateBP6BS2
The NM_004984.4(KIF5A):c.1176G>C(p.Glu392Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000248 in 1,613,890 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. E392E) has been classified as Benign.
Frequency
Consequence
NM_004984.4 missense
Scores
Clinical Significance
Conservation
Publications
- amyotrophic lateral sclerosis, susceptibility to, 25Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Illumina, Labcorp Genetics (formerly Invitae)
- inherited neurodegenerative disorderInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- myoclonus, intractable, neonatalInheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, LIMITED Submitted by: Ambry Genetics, Illumina, G2P, Labcorp Genetics (formerly Invitae)
- hereditary spastic paraplegia 10Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
- autosomal dominant Charcot-Marie-Tooth disease type 2 due to KIF5A mutationInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -7 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| KIF5A | ENST00000455537.7 | c.1176G>C | p.Glu392Asp | missense_variant | Exon 12 of 29 | 1 | NM_004984.4 | ENSP00000408979.2 |
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152258Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000279 AC: 7AN: 250742 AF XY: 0.0000369 show subpopulations
GnomAD4 exome AF: 0.0000233 AC: 34AN: 1461632Hom.: 0 Cov.: 32 AF XY: 0.0000275 AC XY: 20AN XY: 727066 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152258Hom.: 0 Cov.: 32 AF XY: 0.0000403 AC XY: 3AN XY: 74396 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The c.1176G>C (p.E392D) alteration is located in exon 12 (coding exon 12) of the KIF5A gene. This alteration results from a G to C substitution at nucleotide position 1176, causing the glutamic acid (E) at amino acid position 392 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.
Spastic paraplegia Benign:1
not provided Benign:1
KIF5A: BP4, BS1
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at